Parallax Volatility Advisers’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,080
Closed -$322K 3882
2020
Q4
$322K Buy
+4,080
New +$239K ﹤0.01% 2632
2019
Q3
Sell
-4,082
Closed -$329K 3805
2019
Q2
$329K Buy
+4,082
New +$287K ﹤0.01% 1618
2018
Q1
Sell
-5,544
Closed -$570K 4861
2017
Q4
$570K Buy
+5,544
New +$552K ﹤0.01% 1458

Other funds holding CMD

Parallax Volatility Advisers's CMD Position: Q1 2021 in Review

Parallax Volatility Advisers sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 4,080 shares — an estimated $322K sold.

Parallax Volatility Advisers first reported a position in CMD in Q4 2017 and held it in 3 quarters. The position peaked at $570K in Q4 2017. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Parallax Volatility Advisers reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 4,080 Cantel Medical Corporation shares in Q1 2021, an estimated $322K.
  • Parallax Volatility Advisers first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 3 quarters.
  • Parallax Volatility Advisers's Cantel Medical Corporation position peaked at $570K in Q4 2017.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Parallax Volatility Advisers's 13F filing for Q1 2021, filed 14 May 2021.